chr8-66177022-C-T

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_000756.4(CRH):​c.456G>A​(p.Arg152Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00217 in 1,614,034 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0015 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0022 ( 21 hom. )

Consequence

CRH
NM_000756.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.09

Publications

0 publications found
Variant links:
Genes affected
CRH (HGNC:2355): (corticotropin releasing hormone) This gene encodes a member of the corticotropin-releasing factor family. The encoded preproprotein is proteolytically processed to generate the mature neuropeptide hormone. In response to stress, this hormone is secreted by the paraventricular nucleus (PVN) of the hypothalamus, binds to corticotropin releasing hormone receptors and stimulates the release of adrenocorticotropic hormone from the pituitary gland. Marked reduction in this protein has been observed in association with Alzheimer's disease. Autosomal recessive hypothalamic corticotropin deficiency has multiple and potentially fatal metabolic consequences including hypoglycemia and hepatitis. In addition to production in the hypothalamus, this protein is also synthesized in peripheral tissues, such as T lymphocytes, and is highly expressed in the placenta. In the placenta it is a marker that determines the length of gestation and the timing of parturition and delivery. A rapid increase in circulating levels of the hormone occurs at the onset of parturition, suggesting that, in addition to its metabolic functions, this protein may act as a trigger for parturition. [provided by RefSeq, Nov 2015]
LINC00967 (HGNC:48725): (long intergenic non-protein coding RNA 967)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 8-66177022-C-T is Benign according to our data. Variant chr8-66177022-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 585726.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.09 with no splicing effect.
BS2
High AC in GnomAd4 at 225 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CRHNM_000756.4 linkc.456G>A p.Arg152Arg synonymous_variant Exon 2 of 2 ENST00000276571.5 NP_000747.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CRHENST00000276571.5 linkc.456G>A p.Arg152Arg synonymous_variant Exon 2 of 2 1 NM_000756.4 ENSP00000276571.3
LINC00967ENST00000729586.1 linkn.-240C>T upstream_gene_variant
LINC00967ENST00000729591.1 linkn.-216C>T upstream_gene_variant

Frequencies

GnomAD3 genomes
AF:
0.00148
AC:
226
AN:
152240
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.00548
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00786
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00188
Gnomad OTH
AF:
0.00334
GnomAD2 exomes
AF:
0.00314
AC:
788
AN:
250622
AF XY:
0.00402
show subpopulations
Gnomad AFR exome
AF:
0.000124
Gnomad AMR exome
AF:
0.00122
Gnomad ASJ exome
AF:
0.00458
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000232
Gnomad NFE exome
AF:
0.00203
Gnomad OTH exome
AF:
0.00343
GnomAD4 exome
AF:
0.00225
AC:
3284
AN:
1461676
Hom.:
21
Cov.:
31
AF XY:
0.00267
AC XY:
1943
AN XY:
727120
show subpopulations
African (AFR)
AF:
0.000329
AC:
11
AN:
33462
American (AMR)
AF:
0.00134
AC:
60
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.00494
AC:
129
AN:
26120
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.0131
AC:
1130
AN:
86206
European-Finnish (FIN)
AF:
0.000562
AC:
30
AN:
53402
Middle Eastern (MID)
AF:
0.00330
AC:
19
AN:
5766
European-Non Finnish (NFE)
AF:
0.00157
AC:
1747
AN:
1111938
Other (OTH)
AF:
0.00262
AC:
158
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
204
408
613
817
1021
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00148
AC:
225
AN:
152358
Hom.:
1
Cov.:
32
AF XY:
0.00138
AC XY:
103
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.000240
AC:
10
AN:
41588
American (AMR)
AF:
0.00124
AC:
19
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00548
AC:
19
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00766
AC:
37
AN:
4828
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00188
AC:
128
AN:
68040
Other (OTH)
AF:
0.00331
AC:
7
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
12
24
35
47
59
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00191
Hom.:
1
Bravo
AF:
0.00144
Asia WGS
AF:
0.00404
AC:
14
AN:
3478
EpiCase
AF:
0.00251
EpiControl
AF:
0.00237

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 28, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jul 24, 2016
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

CRH-related disorder Benign:1
Oct 14, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.33
CADD
Benign
11
DANN
Benign
0.96
PhyloP100
2.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144205489; hg19: chr8-67089257; API